Bavarian Nordic — August 2024
-
Børsen i dag - helsides artikel side 4: Vil anbefale at købe adgang til artiklen, hvor PC bl.a. oplyser, at en ordre på fx yderligere 2 mio. vacciner i år ikke nødvendigvis vil føre til en opjustering, idet anden produktion sikkert skal tilsidesættes https://e-avis.borsen.dk/p/boersen/23-08-2024/r/3/4-5/2723/1520725 paywall.
-
Jo flere vacciner WHO godkender, jo mere usikkert skulle man tro det bliver at etablere produktion i afrika. For jo flere producenter der må være med jo større usikkerhed bliver der både om fremtidige ordrestørrelser plus usikkerhed om, hvad der sker med
prisen herpå. -
Kan ikke huske om denne har været publiceret i chatten før - Commission asks EU countries to pledge mpox vaccines for Africa by end of August https://www.politico.eu/article/european-commission-stella-kyriakides-health-ministers-eu-countries-mpox-vaccine-africa-outbreak/
-
Africa: Update on the Mpox Outbreak in Africa: https://allafrica.com/stories/202408230414.html
-
LSHTM d.d. "Mpox: what our experts are saying" https://www.lshtm.ac.uk/newsevents/news/2024/mpox-what-our-experts-are-saying Meget kendt stof men godt at høre, at "The teams in DRC are very experienced, and with the right resources, they can handle it. But what’s required is vaccine access.”
-
Men mener jeg så en artikeln omkring at dem som havde "Gl. koppevaccinationer, som de fik som barn" her var effekten af ny Mpox vaccine skud blivende. Hvor imod effekten forsvandt ved dem der ikke havde været børnevaccineret omod kopper... men er ikke helt sikker i konklusionen - kan ikke lige finde denne undersøgelse
-
@Yahoo 16.57: EPIDEMIOLOGICAL SITUATION
From 1 st January 2024 to 23 Aug 2024, a total of 21,466 cases (3,350 confirmed; 18,116 suspected) and 591 deaths [case fatality rate (CFR): 2.9%] of Mpox have been reported from 13 Africa Union (AU) Member States (MS): Burundi, Cameroon, Central Africa Republic, Congo, Côte d’Ivoire, Democratic Republic of Congo, Gabon, Liberia, Kenya, Nigeria, Rwanda, South Africa and Uganda.
-
CHALLENGES
There are still some challenges identified like:
Low level of domestic resources from Member States,
Only 3 African countries already approved the utilization of the Mpox vaccines (Nigeria, South Africa and DRC). It is critical for other countries to approve the introduction of the vaccines
-
The tension of the increasing demand of the vaccines by western nation and the monopoly in the manufacturing of vaccines (BN is the only one currently manufacturing this vaccine), puts Africa at a disadvantage in securing the vaccines given the limited market demand by African leaders.
There is a serious risk that Africa will not be consider in the distribution of the vaccines and other medical countermeasures if African leaders don’t come strongly together to make their voice... etc etc
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind